Jenburkt Pharmaceuticals
1,182.70
+19.75(+1.70%)
Market Cap₹521.92 Cr
PE Ratio15.82
IndustryHealthcare
Company Performance:
1D+1.70%
1M-6.13%
6M+18.33%
1Y0.00%
5Y+226.22%
View Company Insightsright
Latest news about Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Reports Strong Q4 Results, Announces Dividend May 20, 2025
Jenburkt Pharmaceuticals released its Q4 financial results, showing significant growth. Revenue increased by 5.80% to ₹410.50 crore. EBITDA rose by 10.25% to ₹108.60 crore, with the EBITDA margin expanding to 26.45%. Net profit grew by 8.10% to ₹85.40 crore. The company also announced a dividend of ₹18.00 per equity share.